These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2510589

  • 21. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J.
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain.
    Tekes K, Tóthfalusi L, Gaál J, Magyar K.
    Pol J Pharmacol Pharm; 1988; 40(6):653-8. PubMed ID: 3152003
    [Abstract] [Full Text] [Related]

  • 25. Thiol redox state and lipid and protein oxidation in the mouse striatum after pentylenetetrazol-induced epileptic seizure.
    Patsoukis N, Zervoudakis G, Georgiou CD, Angelatou F, Matsokis NA, Panagopoulos NT.
    Epilepsia; 2005 Aug; 46(8):1205-11. PubMed ID: 16060929
    [Abstract] [Full Text] [Related]

  • 26. Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione.
    Spina MB, Cohen G.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):502-7. PubMed ID: 3183949
    [Abstract] [Full Text] [Related]

  • 27. Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease.
    Youdim MB.
    J Neural Transm Suppl; 1986 Nov; 22():91-105. PubMed ID: 3097263
    [Abstract] [Full Text] [Related]

  • 28. Intramitochondrial formation of oxidized glutathione during the oxidation of benzylamine by monoamine oxidase.
    Werner P, Cohen G.
    FEBS Lett; 1991 Mar 11; 280(1):44-6. PubMed ID: 1901277
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Thiol redox state and oxidative stress in midbrain and striatum of weaver mutant mice, a genetic model of nigrostriatal dopamine deficiency.
    Patsoukis N, Papapostolou I, Zervoudakis G, Georgiou CD, Matsokis NA, Panagopoulos NT.
    Neurosci Lett; 2005 Mar 07; 376(1):24-8. PubMed ID: 15694268
    [Abstract] [Full Text] [Related]

  • 32. The amphetamine-like reinforcing effect and mechanism of L-deprenyl on conditioned place preference in mice.
    Wu WR, Zhu XZ.
    Eur J Pharmacol; 1999 Jan 01; 364(1):1-6. PubMed ID: 9920178
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dopamine turnover and glutathione oxidation: implications for Parkinson disease.
    Spina MB, Cohen G.
    Proc Natl Acad Sci U S A; 1989 Feb 01; 86(4):1398-400. PubMed ID: 2919185
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl.
    Knoll J, Dallo J, Yen TT.
    Life Sci; 1989 Feb 01; 45(6):525-31. PubMed ID: 2505007
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.